tiprankstipranks
Trending News
More News >
Addus Homecare (ADUS)
NASDAQ:ADUS
Advertisement

Addus Homecare (ADUS) AI Stock Analysis

Compare
351 Followers

Top Page

ADUS

Addus Homecare

(NASDAQ:ADUS)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
$127.00
▲(5.03% Upside)
Addus Homecare's strong financial performance and positive earnings call sentiment are the primary drivers of its stock score. The company's strategic acquisitions and revenue growth in the personal care segment bolster its future prospects. However, technical indicators suggest short-term bearishness, and valuation metrics indicate moderate attractiveness. Challenges in the home health sector and hiring difficulties present risks that need to be addressed.
Positive Factors
Revenue Growth
The significant revenue growth indicates strong demand for Addus Homecare's services, reflecting successful market penetration and service expansion.
Strategic Acquisitions
Strategic acquisitions expand market presence and revenue base, enhancing competitive positioning and long-term growth potential.
Cash Flow Management
Robust cash flow management ensures financial flexibility, supporting ongoing operations and strategic investments for sustained growth.
Negative Factors
Medicare Payment Concerns
Potential Medicare payment cuts could impact revenue streams, posing a risk to profitability and growth in the home health segment.
Home Health Revenue Decline
Declining revenue in the home health segment suggests challenges in maintaining growth, potentially affecting overall company performance.
Urban Hiring Challenges
Hiring challenges in urban areas may limit service delivery and expansion, impacting the company's ability to meet demand effectively.

Addus Homecare (ADUS) vs. SPDR S&P 500 ETF (SPY)

Addus Homecare Business Overview & Revenue Model

Company DescriptionAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
How the Company Makes MoneyAddus Homecare generates revenue primarily through the provision of home health care services, which are often reimbursed by government programs such as Medicare and Medicaid, as well as private insurance plans. The company charges for its services based on the hours of care provided and the specific needs of each client. Key revenue streams include personal care services, skilled nursing services, and therapy services. Additionally, Addus Homecare benefits from partnerships with healthcare providers and organizations, allowing them to expand their service offerings and reach a broader client base. Their growth strategy also involves acquiring smaller home care agencies, which not only increases their market presence but also contributes to their overall earnings through the integration of these new clients into their existing service framework.

Addus Homecare Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 02, 2026
Earnings Call Sentiment Neutral
The earnings call displayed strong revenue growth and successful expansion through acquisitions, particularly in the personal care segment. However, there are challenges in the home health sector due to potential Medicare payment cuts and hiring difficulties in urban areas. The positive momentum in personal care and strategic acquisitions indicate future growth potential.
Q3-2025 Updates
Positive Updates
Strong Revenue and EBITDA Growth
Total revenue for Q3 2025 was $362.3 million, a 25% increase compared to Q3 2024. Adjusted EBITDA increased by 31.6% to $45.1 million.
Significant Personal Care Segment Growth
Personal care segment saw a 6.6% same-store revenue growth with a 2.4% increase in hours per business day. The Texas and Illinois rate increases are expected to contribute approximately $35.2 million in annualized revenue.
Expansion Through Acquisitions
Acquisition of Del Cielo Home Care Services in South Texas, adding $12.7 million in annualized revenue. Previous acquisitions in 2025 include Gentiva and Helping Hands, expanding market presence.
Improved Hiring Performance
Achieved 113 hires per business day, a 6.6% increase over the previous quarter. Strong hiring trends supported organic growth.
Negative Updates
Home Health Revenue Decline
Same-store revenue for home health decreased by 2.8% compared to Q3 2024. Challenges in achieving growth due to rate uncertainty.
Medicare Payment Concerns
Potential 6.4% aggregate reduction in Medicare payments to home health agencies in 2026, creating uncertainty and affecting acquisition opportunities.
Challenges in Urban Clinical Hiring
Ongoing difficulties in hiring skilled clinical staff in urban markets, impacting service delivery.
Company Guidance
During Addus HomeCare's Third Quarter 2025 Earnings Conference Call, the company reported a total revenue of $362.3 million, marking a 25% increase from the same quarter in 2024. This growth translated to an adjusted earnings per share of $1.56, up 20% from the prior year's $1.30. The company's adjusted EBITDA reached $45.1 million, reflecting a 31.6% increase. Addus highlighted strong operating cash flow exceeding $50 million and ended the quarter with $102 million in cash and a net leverage of under 1x adjusted EBITDA. The company noted a 6.6% same-store revenue growth in its personal care segment, with a 2.4% increase in same-store hours and significant hiring momentum, achieving 113 hires per business day, up 6.6% from the previous quarter. In the hospice segment, same-store revenue grew by 19% year-over-year, with a 9.5% increase in the average daily census. Conversely, the home health segment saw a 2.8% decline in same-store revenue. Key developments included a 9.9% rate increase in Texas and an impending 3.9% increase in Illinois, both contributing to substantial revenue growth forecasts. The company also emphasized its acquisition strategy, notably the recent acquisition of Del Cielo's personal care operations, enhancing its market presence in Texas.

Addus Homecare Financial Statement Overview

Summary
Addus Homecare exhibits strong financial health with consistent revenue growth, stable profitability, and a solid balance sheet. The company's low leverage and effective cash flow management position it well for future growth. However, maintaining operating efficiency and enhancing profitability will be key areas to focus on to sustain its competitive edge in the medical care facilities industry.
Income Statement
85
Very Positive
Addus Homecare has demonstrated consistent revenue growth with a TTM revenue growth rate of 5.69%, supported by a stable gross profit margin of approximately 32.66%. The net profit margin remains steady at 6.36%, indicating efficient cost management. However, the EBIT margin has slightly decreased over time, suggesting potential pressure on operating efficiency.
Balance Sheet
78
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.05, reflecting prudent financial leverage. Return on equity is healthy at 8.49%, indicating effective use of equity capital. The equity ratio stands at a robust level, showcasing financial stability. However, the slight decrease in ROE from previous years suggests a need for improved profitability.
Cash Flow
80
Positive
Addus Homecare's cash flow position is solid, with a positive free cash flow growth rate of 2.87% in the TTM period. The operating cash flow to net income ratio of 0.66 indicates good cash generation relative to earnings. The free cash flow to net income ratio is strong at 0.98, highlighting effective cash conversion. Continued focus on cash flow management will be crucial for sustaining growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.42B1.15B1.06B951.12M864.50M764.77M
Gross Profit1.11B375.02M339.88M299.74M269.85M226.24M
EBITDA357.49M120.61M106.56M83.14M80.70M57.18M
Net Income217.00M73.60M62.52M46.02M45.13M33.13M
Balance Sheet
Total Assets1.42B1.41B1.02B937.99M947.59M892.58M
Cash, Cash Equivalents and Short-Term Investments101.92M98.91M64.79M79.96M168.90M145.08M
Total Debt202.49M273.13M175.18M178.05M263.55M239.67M
Total Liabilities372.96M442.14M317.73M304.45M373.24M373.91M
Stockholders Equity1.05B970.49M706.69M633.54M574.34M518.68M
Cash Flow
Free Cash Flow297.87M110.38M102.79M96.81M34.84M102.58M
Operating Cash Flow308.94M116.43M112.25M105.11M39.49M109.41M
Investing Cash Flow-799.38M-354.61M-119.24M-106.59M-42.02M-214.24M
Financing Cash Flow270.05M272.30M-8.18M-87.45M26.34M138.19M

Addus Homecare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price120.92
Price Trends
50DMA
115.51
Positive
100DMA
113.62
Positive
200DMA
109.39
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
61.56
Neutral
STOCH
94.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADUS, the sentiment is Positive. The current price of 120.92 is above the 20-day moving average (MA) of 113.93, above the 50-day MA of 115.51, and above the 200-day MA of 109.39, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 61.56 is Neutral, neither overbought nor oversold. The STOCH value of 94.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADUS.

Addus Homecare Risk Analysis

Addus Homecare disclosed 31 risk factors in its most recent earnings report. Addus Homecare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Addus Homecare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$927.11M35.4310.87%29.89%10.33%
74
Outperform
$2.23B25.888.58%18.77%6.88%
72
Outperform
$2.13B21.169.94%1.97%23.74%-18.99%
56
Neutral
$1.16B121.321.29%68.17%-85.42%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
41
Neutral
$275.41M-73.31%5.21%5.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADUS
Addus Homecare
120.92
-2.17
-1.76%
NHC
National Healthcare
137.18
12.76
10.26%
ASTH
Astrana Health
23.05
-21.76
-48.56%
PNTG
Pennant Group
28.09
-3.47
-10.99%
AGL
Agilon Health
0.66
-1.64
-71.30%

Addus Homecare Corporate Events

Addus HomeCare Reports Strong Q3 2025 Results
Nov 5, 2025

Addus HomeCare Corporation, a prominent provider of home care services, operates primarily in the personal care, hospice, and home health sectors, catering to individuals at risk of hospitalization or institutionalization. In its latest earnings report, Addus HomeCare announced a robust financial performance for the third quarter of 2025, highlighted by a 25% increase in net service revenues to $362.3 million and a net income of $22.8 million. The company also reported a significant rise in adjusted EBITDA by 31.6% year-over-year, reaching $45.1 million, and completed the acquisition of Del Cielo Home Care Services, further expanding its operations in Texas. Key drivers of growth included strong performance in the personal care segment, which accounted for 76.1% of revenues, and a notable 19% organic revenue growth in the hospice care segment. The acquisition of Del Cielo is expected to enhance Addus’s market presence in Texas, complementing previous acquisitions and supporting strategic growth initiatives. Looking forward, Addus HomeCare remains optimistic about its growth prospects, leveraging strong organic growth and strategic acquisitions to expand its market coverage and enhance shareholder value.

Addus HomeCare Q3 2025 Earnings: Growth Amid Challenges
Nov 5, 2025

Addus HomeCare Corporation’s latest earnings call revealed a generally positive sentiment, marked by strong revenue growth and successful expansion through strategic acquisitions. The company’s personal care segment showed significant promise, although challenges persist in the home health sector, particularly due to potential Medicare payment cuts and hiring difficulties in urban areas. Nevertheless, the positive momentum in personal care and strategic acquisitions indicate future growth potential.

Financial DisclosuresM&A Transactions
Addus HomeCare Reports Strong Q3 2025 Financial Results
Positive
Nov 3, 2025

On November 3, 2025, Addus HomeCare Corporation announced its financial results for the third quarter of 2025, showing a 25.0% increase in net service revenues to $362.3 million and a 31.6% rise in adjusted EBITDA to $45.1 million compared to the same period in 2024. The company completed the acquisition of Del Cielo Home Care Services on October 1, 2025, expanding its personal care operations in Texas, which is expected to positively impact its financial results and market coverage.

The most recent analyst rating on (ADUS) stock is a Buy with a $132.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 13, 2025